Kenvue Inc., Johnson & Johnson’s stand-alone company for consumer health brands, has filed for an initial public offering.
The selling is part of Kenvue’s previously announced separation from Johnson & Johnson, which will retain the name of the firm that houses its prescription-drug and medical-devices divisions. Kenvue will be in charge of brands such as Band-Aid and Tylenol.
Kenvue has registered for an initial public offering with the Securities and Exchange Commission, however the financial details of the anticipated offering were not disclosed in a Wednesday filing.
Johnson & Johnson will receive the entire net proceeds from the sale of shares in the transaction, according to the business.
Kenvue will petition for its shares to be listed under the symbol KVUE.